Back to search

Growth in use of statins after trials is not targeted to most appropriate patients

Data up to Jan 2025

Published2000
Citations47
References13

Total Citations Per Year

Abstract

References (13)

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 8,631 citations

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

1996 • 7,450 citations

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

1995 • 7,378 citations

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

1998 • 5,293 citations

Prevention of coronary heart disease in clinical practice

1994 • 1,133 citations

Geographic Variation in the Treatment of Acute Myocardial Infarction

1999 • 343 citations

Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study

1995 • 186 citations

Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table

1996 • 169 citations

From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia

1998 • 140 citations

The Influence of Hospital-Based Prescribers on Prescribing in General Practice

1999 • 92 citations

Time trend analysis and variations in prescribing lipid lowering drugs in general practice

1998 • 59 citations

The Influence of Pharmacoeconomic Factors on Prescribing Patterns in Ireland

1992 • 21 citations

Drug Rationing in the UK National Health Service

1997 • 9 citations

Cited By (0)

Loading...
Growth in use of statins after trials is not targeted to most appropriate patients (2000) – Clinical Pharmacology & Therapeutics | Metascience Observatory Explorer